0% found this document useful (0 votes)
107 views3 pages

Keith Yamamoto: Biochemist & Policy Leader

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
107 views3 pages

Keith Yamamoto: Biochemist & Policy Leader

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Keith Yamamoto

Keith R. Yamamoto (born February 4, 1946) is vice


chancellor of Science Policy and Strategy and Keith R. Yamamoto
professor of Cellular and Molecular Pharmacology at
the University of California, San Francisco, (UCSF).
He is known for his Molecular Biology and
Biochemistry research on nuclear receptors and his
involvement in science policy and precision medicine.

Yamamoto identified the genomic sequences to which


the glucocorticoid receptor (GR) binds in order to
control gene transcription[1] termed "glucocorticoid
response elements".[2] In science policy, he has served
as Chairman of the Board on Life Sciences at the
National Academy of Sciences,[3] as well as serving on
numerous government and public advisory boards,
including the NIH Center for Scientific Review
Advisory Council. Born February 4, 1946
Des Moines, Iowa,
United States

Research career Alma mater Iowa State University, Princeton


University
Yamamoto was born in Des Moines, Iowa, and Scientific career
graduated from Iowa State University with a B.S. in Fields Biochemistry
Biochemistry and Biophysics in 1968. At Iowa State,
Institutions University of California, San
he was a member of the Delta Upsilon fraternity.[4] He
Francisco
earned his doctorate in Biochemical Sciences at
Princeton University in 1973 in the laboratory of Bruce
Alberts for his research on the estrogen receptor (ER).[5] He then began his research on the glucocorticoid
receptor as a postdoctoral fellow with Gordon Tomkins at UCSF.

In 1976, Yamamoto joined the Department of Biochemistry and Biophysics at the University of
California, San Francisco (UCSF) as an Assistant Professor. In 1978, he became an associate professor
and in 1983 a full professor. He also took on the role of Vice-Chair of the Department of Biochemistry
and Biophysics at UCSF in 1985. In 2015, Yamamoto became UCSF's first vice chancellor of science
policy and strategy. He was previously the vice chancellor of research for the university, and the vice
dean, Research, within the School of Medicine.
Yamamoto was elected a fellow of the American Academy of Arts and Sciences in 1989,[6] elected to the
National Academy of Sciences in 1989, and to the American Association for the Advancement of Science
in 2002. Yamamoto ran a research lab focused on understanding signaling and transcriptional control by
nuclear receptors and continues to teach graduate courses in molecular biology and biochemistry at
UCSF.

Political career
Throughout his career, Dr. Yamamoto has also been committed to public and science policy. In the 1980s
he argued against the development of biological warfare by the U.S. Department of Defense.[7][8] In 1986
he co-authored with Charles Piller a book, "The Rebirth of American Biological Warfare:GENE WARS
Military Control Over the New Genetic Technologies", disclosing the history of the use of biological
weapons in the United States and advising against continuing these programs.[9]

Dr. Yamamoto has served on several committees that oversee the NIH peer review process which
allocates funding to research investigators. He was Chairman of the NIH Center for Scientific Review
Advisory Committee from 1996-2000. From 2007-2008 he co-chaired The Advisory Committee to the
Director Working Group on Peer Review and the Advisory Committee to the NIH Director from 2007-
2010. He had advocated for streamlining the science grant review process and for devising strategies for
focusing NIH funding on research that will have the greatest impact in the field.[10] In 2008, he was
nominated as one of 10 Influential People to Watch in Biomedical Policy.[3]

In April 2022, Dr. Yamamoto was elected as President of the American Association of the Advancement
of Science (AAAS), the largest multidisciplinary scientific society in the world.

Publications
Research publications at Pubmed ([Link]
Author%5D&cauthor=true&cauthor_uid=206732)

References
1. Ucker, DS; Ross, SR; Yamamoto, KR (December 1981). "Mammary tumor virus DNA
contains sequences required for its hormone regulated transcription". Cell. 27 (2 Part 1):
257–266. doi:10.1016/0092-8674(81)90409-8 ([Link]
1%2990409-8). PMID 6277499 ([Link]
S2CID 37961743 ([Link]
2. Chandler, VL; Maler, BA; Yamamoto; KR (June 1983). "DNA sequences bound specifically
by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in
vivo". Cell. 33 (2): 489–499. doi:10.1016/0092-8674(83)90430-0 ([Link]
F0092-8674%2883%2990430-0). PMID 6190571 ([Link]
1).
3. Schubert, Charlotte (2008). "10 influential people to watch in biomedical policy". Nature
Medicine. 14 (10): 1004–1005. doi:10.1038/nm1008-1004 ([Link]
08-1004). S2CID 38846080 ([Link]
4. Bomb Yearbook. Ames, Iowa: Iowa State University of Science and Technology. 1968.
p. 200.
5. Yamamoto, Keith; Bruce Alberts (1 August 1972). "In vitro conversion of estradiol-receptor
protein to its nuclear form: dependence on hormone and DNA" ([Link]
v/pmc/articles/PMC426878). Proc. Natl. Acad. Sci. 69 (8): 2105–2109.
Bibcode:1972PNAS...69.2105Y ([Link]
doi:10.1073/pnas.69.8.2105 ([Link] PMC 426878 (htt
ps://[Link]/pmc/articles/PMC426878). PMID 4506080 ([Link]
[Link]/4506080).
6. "Book of Members, 1780-2010: Chapter XYZ" ([Link]
edia/document/2019-10/[Link]) (PDF). American Academy of Arts and Sciences.
Retrieved 14 April 2022.
7. Croddy, Eric (1997). Chemical and Biological Warfare: An Annotated Bibliography.
Maryland: Scarecrow Press. p. 124.
8. Yamamoto, Keith R. (August 1989). "Retargeting Research on Biological Weapons".
Technology Review: 23–24.
9. Kelves, Daniel (8 May 1988). "The Rebirth of American Biological Warfare : GENE WARS
Military Control Over the New Genetic Technologies by Charles Piller and Keith R.
Yamamoto" ([Link] Los
Angeles Times.
10. Pfeffer, Suzanne (February 2011). "The Yamamoto Plan" ([Link]
y/asbmbtoday_article.aspx?id=11326&page_id=1). ASBMB Today.

External links
Keith Yamamoto's Short Talk: "Taking Risks" ([Link]
ment/taking-risks-in-science/)
Yamamoto Lab website ([Link]

Retrieved from "[Link]

Common questions

Powered by AI

Key themes in Keith Yamamoto's work include molecular signaling via nuclear receptors, science policy reform, and ethical conduct in scientific practice . His efforts to uncover the molecular basis of hormone action reflect a commitment to advancing fundamental knowledge. Simultaneously, his intensity in reforming science policy to optimize research funding and ethical standards showcases his dedication to ensuring that scientific progress benefits society responsibly. These intersect through his advocacy for policies that support impactful, ethically sound scientific research .

Keith Yamamoto has contributed to molecular biology by identifying the genomic sequences that the glucocorticoid receptor (GR) binds to, known as glucocorticoid response elements, which control gene transcription . His pioneering work on DNA sequences bound by glucocorticoid receptors in vitro has shown how these sequences can render promoters hormone-responsive in vivo, establishing a mechanistic link between nuclear receptor signaling and transcriptional control . This has provided critical insights into the molecular processes underpinning cellular responses to hormones.

Yamamoto's contributions to biochemistry, particularly in elucidating nuclear receptor functions, inform his science policy leadership by underpinning innovative practices with solid scientific understanding . At UCSF, his research-focused insights enable the integration of strategic policy development that aligns with cutting-edge science, ensuring that institutional objectives support scientific advancement effectively and ethically . Beyond UCSF, his leadership roles harness these insights to advocate for national policies that promote scientific integrity and societal benefit.

Keith Yamamoto's stance against biological warfare ethically aligns with his scientific achievements that emphasize the responsible use of biochemistry and molecular biology . By co-authoring 'The Rebirth of American Biological Warfare,' he critically examined military control over genetic technologies, advocating for research policies that prioritize human welfare over militaristic goals . This position not only reflects a commitment to scientific integrity and public health but also establishes a standard for ethical accountability in scientific inquiry.

Keith Yamamoto has significantly influenced science policy through various leadership roles, including serving as Chairman of the National Academy of Sciences' Board on Life Sciences and the NIH Center for Scientific Review Advisory Committee . His research background in molecular biology and biochemistry, particularly on nuclear receptors, provides him with a strong scientific foundation to address impactful scientific funding and policy issues . Yamamoto's advocacy against biological weapons in the 1980s and his efforts to streamline NIH grant reviews further demonstrate his commitment to aligning scientific practices with ethical standards and efficient resource distribution .

The intersection of Keith Yamamoto's research and advocacy is evident in the ethical dimensions he emphasizes between scientific discovery and application. His research on glucocorticoid receptors advances biological understandings crucial for medical fields, while his advocacy against biological warfare underscores a commitment to ensuring such knowledge serves constructive rather than destructive purposes . This advocacy highlights the importance of ethical frameworks in guiding the application of scientific advancements.

Keith Yamamoto's academic affiliations with institutions like Iowa State University and Princeton University laid the foundation for his scientific inquiry into biochemistry and biophysics . At UCSF, his progression from Assistant Professor to influential administrative roles allowed him to leverage institutional resources to advance his research on nuclear receptors and amplify his impact on science policy . These affiliations provided him with platforms to integrate scientific research with crucial policy dialogue on a national and international scale.

Keith Yamamoto advocated for streamlining the science grant review process and devising strategies to focus NIH funding on projects with the highest potential impact . His initiatives on the NIH committees, including serving on the Advisory Committee to the Director’s Working Group on Peer Review, reflect a priority for optimizing resource allocation and enhancing the efficiency of scientific research funding mechanisms . These efforts demonstrate his commitment to ensuring that public funds are used effectively to advance significant scientific advancements.

As UCSF's first vice chancellor of science policy and strategy, Keith Yamamoto has likely influenced the university's research landscape by integrating strategic direction with scientific acuity . His role involves overseeing policy development that aligns scientific efforts with broader institutional and societal goals, which fosters a research environment that is both innovative and ethically responsible . By establishing this bridge between policy and cutting-edge science, Yamamoto helps position UCSF as a leader in both scientific discovery and application.

Keith Yamamoto played pivotal roles in transforming NIH's peer review processes through his chairmanship of committees tasked with reviewing and offering reforms for the system . He advocated for process streamlining and strategic funding allocations in alignment with impactful research . The anticipated outcomes included increased efficiency, reduced administrative burden, and enhanced alignment of funded projects with public health priorities, thereby fostering innovation and scientific breakthroughs.

You might also like